miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance

Multiple myeloma (MM) produces clonal plasma cells and aberrant monoclonal antibody accumulation in patients’ bone marrow (BM). Around 1% of all cancers and 13% of hematological malignancies are caused by MM, making it one of the most common types of cancer. Diagnostic and therapeutic methods for ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Tavakoli Pirzaman, Ali, Ebrahimi, Pouyan, Hasanpour, Amir Hossein, Shakeri, Mahdi, Babajani, Bahareh, Pourali Ganji, Zahra, Babaei, Hedye, Rahmati, Amirhossein, Hosseinzadeh, Rezvan, Doostmohamadian, Shahrbanoo, Kazemi, Sohrab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515583/
https://www.ncbi.nlm.nih.gov/pubmed/37728167
http://dx.doi.org/10.1177/15330338231202391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515583/
https://www.ncbi.nlm.nih.gov/pubmed/37728167
http://dx.doi.org/10.1177/15330338231202391

Ejemplares similares